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Introduction
Conversion of adenosine to inosine within RNA drastically
alters the base-pairing ability of the RNA and introduces
diversity. In mRNA, inosine is translated as if it were guanosine
(Basilio et al., 1962), whereas, in tRNA, inosine at position 34
or 37 influences base-pairing at the anticodon loop (for a review,
see Keller et al., 1999). The adenosine deaminase acting on
RNA (ADAR) family of enzymes convert adenosine to inosine
in mRNA, whereas the adenosine deaminase acting on tRNA
(ADAT) family deaminate adenosine to inosine in tRNA.
ADAR activity has been found in all metazoan species that
have been examined. In mammals, there are three members of
the ADAR family: ADAR1 and ADAR2 convert specific
adenosine to inosine in pre-mRNA and can also convert up to
40-50% of the adenosines in long synthetic duplex RNAs (for
a review, see Keegan et al., 2001). To date, no enzymatic
activity has been detected for ADAR3 (Chen et al., 2000).
ADAR1 and ADAR2 are expressed in most tissues but the pre-
mRNAs that have been identified that are edited generally
encode receptors of the central nervous system (for a review,
see Emeson and Singh, 2000). These transcripts include the
glutamate-gated ion channel receptors (GluR), the serotonin-
2C receptor as well as a transcript encoding ADAR2 itself.
Editing of transcripts can dramatically alter the properties of
the receptor, for example editing of the Q/R site in GluR-B
results in a glutamine codon being converted to an arginine
codon, thereby generating a receptor impermeable to calcium
ions (Sommer et al., 1991). Viral transcripts are also edited and
these include transcripts of the hepatitis delta virus (Taylor,
1990) and DNA virus transcripts such as those of polyoma
virus (Kumar and Carmichael, 1997). Highly edited transcripts
of the polyoma virus accumulate in the nucleus and are not
exported (Zhang and Carmichael, 2001). A sequence specific
endonuclease that cleaves inosines in hyperedited RNA has
been identified in the cytoplasm (Scadden and Smith, 2001).
This endonuclease might be a means for the removal of hyper-
edited viral RNA.
Because ADAR1 and ADAR2 are very similar, they display
overlapping specificities at some editing sites, such as the
GluR-B R/G site (Melcher et al., 1996; O’Connell et al., 1997).
At other sites, there is an absolute requirement for one enzyme
that cannot be compensated by the presence of the other. This
was observed when transgenic mice were generated lacking
ADAR2 and when heterozygote chimeras were generated for
ADAR1 (Higuchi et al., 2000; Wang et al., 2000). The presence
of the other active enzyme in the transgenic mice could not
rescue the observed phenotype.
ADAT1 converts adenosine to inosine at position 37 that is
b side the anticodon loop and is not essential in yeast (Gerber
et al., 1998). Both ADARs and ADATs are members of the
family of cytosine deaminases (CDAs), containing a deaminase
domain with three distinctive motifs (Gerber and Keller, 2001).
The amino acid residues in these motifs are thought to chelate
a zinc ion at their active site. It has been proposed that the
ADAR family evolved from the ADAT family, which have
similar deaminase domain, and that they acquired double-
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ADAR1 and ADAR2 are editing enzymes that deaminate
adenosine to inosine in long double stranded RNA duplexes
and specific pre-mRNA transcripts. Here, we show that
full-length and N-terminally truncated forms of ADAR1
are simultaneously expressed in HeLa and COS7 cells
owing to the usage of alternative starting methionines.
Because the N-terminus of ADAR1 contains a nuclear
export signal, the full-length protein localizes
predominantly in the cytoplasm, whereas the N-terminally
truncated forms are exclusively nuclear and accumulate in
the nucleolus. ADAR2, which lacks a region homologous to
the N-terminal domain of ADAR1, localizes exclusively to
the nucleus and similarly accumulates in the nucleolus.
Within the nucleolus, ADAR1 and ADAR2 co-localize
in a novel compartment. Photobleaching experiments
demonstrate that, in live cells, ADAR1 and ADAR2 are in
constant flux in and out of the nucleolus. When cells express
the editing-competent glutamate receptor GluR-B RNA,
endogenous ADAR1 and ADAR2 de-localize from the
nucleolus and accumulate at sites where the substrate
transcripts accumulate. This suggests that ADAR1 and
ADAR2 are constantly moving through the nucleolus and
might be recruited onto specific editing substrates present
elsewhere in the cell.
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stranded RNA (dsRNA) binding domains (dsRBDs) to bind to
pre-mRNA (Gerber et al., 1998). The residues in ADATs
involved in binding to tRNA have not yet been identified.
ADAT1 is more similar to the ADARs than ADAT2/3 (Gerber
and Keller, 1999).
ADAR1 has three dsRBDs, whereas ADAR2 has two at the
N-terminus (for a review, see Hough and Bass, 2000). ADAR1
differs from ADAR2 in that it has an extended N-terminus
enriched in RG residues and contains two tandemly arranged
Z-DNA-binding domains (ZBDs). Alternative splicing of
transcripts from constitutively active promoters results in
translation beginning at methionine 296 to produce a protein
of 110 kDa (George and Samuel, 1999b; Kawakubo and
Samuel, 2000). Transcripts from an upstream interferon-
inducible promoter include a new exon 1A that contains a start
codon and encodes a larger protein of 150 kDa. The 150 kDa
protein is observed in the cytoplasm and is involved in the
antiviral pathway, whereas the 110 kDa protein is present in
the nucleus. Recently, a nuclear localization signal (NLS) has
been described for ADAR1 that overlaps with the third dsRBD
(Eckmann et al., 2001), whereas an nuclear export signal
(NES) has been identified at the N-terminus at residue 127
(Poulsen et al., 2001).
Here, we report a systematic analysis of the intracellular
localization of adenosine deaminase enzymes. Our results
indicate that ADAR1 and ADAR2 are in a dynamic flux in and
out of the nucleolus in the living cell. Transient sequestration
of ADAR1 and ADAR2 in the nucleolus might be mediated by
binding to the abundant dsRNA structures associated with
small nucleolar RNAs, because the ADAR-related deaminase




Endogenous adenosine deaminase enzymes were detected using
rabbit polyclonal antibodies raised against different regions of human
ADAR1 (hADAR1) (anti-ADAR1: Ab 007 and Ab 668) and hADAR2
proteins (anti-ADAR2: Ab 70) (O’Connell et al., 1997).
FLAG-tagged constructs were detected using a polyclonal rabbit
antibody anti-FLAG (oct A) (Santa Cruz Biotechnology). His-
tagged constructs were detected using an anti-His monoclonal
antibody (Qiagen). Green fluorescent protein (GFP) was detected
with a mixture of two mouse monoclonal antibodies (anti-GFP
clones 7.1 and 13.1) (Boehringer Mannheim). Goat polyclonal
antibody C-19 (Santa Cruz Biotechnology) recognizes B23
nucleolar phosphoprotein. Additionally, the following antibodies
were used: monoclonal antibody anti-fibrillarin 72B9 (Reimer et al.,
1987); monoclonal antibodies 4F4 and 9H10 directed against
hnRNP C and A, respectively (Burd and Dreyfuss, 1994; Choi and
Dreyfuss, 1984); and monoclonal antibody anti-histone (clone H11-
4, Roche).
Mammalian expression constructs
The polylinker of pSK (O’Connell et al., 1998) contains a unique
EcoRI restriction site and into this site an epitope-tagged cassette was
inserted that encoded an N-terminal FLAG epitope, a SpeI restriction
site and a C-terminal histidine hexamer. Full-length hADAR1 and
hADAR1C-Term (residues 443-1226) were subcloned into this
expression vector via the SpeI restriction site to generate FLAG and
histidine epitope-tagged versions, Flis-ADAR1 and Flis-ADAR1C-
Term (O’Connell et al., 1995). Subsequently full-length hADAR1 and
hADAR1C-Term were excised using the SpeI restriction site and
inserted into the XbaI restriction site in pEGFP-C3 (Clontech), GFP-
ADAR1 and GFP-ADAR1C-Term. To generate GFP-ADAR1N-Term,
ADAR1N-Term (amino acids 1-442) was amplified by PCR with
primers containing SpeI restriction sites and again inserted into the
XbaI restriction site in pEGFP-C3. To generate GFP-ADAR2 and
FlisADAR2, full-length hADAR2 was subcloned into the XbaI
restriction site in pEGFP-C3 vector and into the SpeI restriction site
of the FLAG and histidine epitope tagged vector previously described
(Gerber et al., 1997). Flis-ADAR1 M296A mutant was generated
using the QuickChange kit (Stratagene) and the following primers:
5′-GAGTTTTTAGACGCGGCCGAGATCAAG-3′, 5′-CTTGATCT-
CGGCCGCGTCTAAAAACTC-3′.
GFP-ADAR2 deletions, ∆64-75, ∆64-132 were performed using
ExSite PCR-Based Site-Directed Mutagenesis Kit (Stratagene),
GFPADAR2 as template and the following primers: 5′-GGAGTG-
GCCATTGCTGCCCTCCTCCAG-3′, 5′-CCCGTCCTCCCCAAG-
AACGCCCTGATG-3′ and 5′-CATGCTGCTGAGAAGGCCTTG-
AGGTC-3′. GFP-ADAR2 ∆N was obtained by digestion of GFP-
ADAR2 WT with StuI restriction enzyme and cloned into pEGFP-
C3 vector digested with StuI and SmaI. GFP-N1-ADAR2 was
excised from GFP-ADAR2 WT using EcoRI and StuI restriction
sites and inserted into pEGFP-C3 vector digested with EcoRI and
SmaI.
Full-length human hADAT1 was amplified by PCR from a human
fetal brain cDNA library (Keegan et al., 2000) and inserted in the
pEGFP-C3 vector at the XbaI restriction site to generate GFP-ADAT.
All constructs were confirmed by sequencing.
Cell culture, heterokaryon assays and drugs treatment
Human HeLa, COS7 and murine NIH 3T3 cells were cultured as
monolayers in Modified Eagle’s Medium (MEM) and Dulbecco’s
Modified Eagle’s Medium (DME), respectively (Gibco-BRL, Paisley,
Scotland). All media were supplemented with 10% fetal calf serum
(FCS, Gibco-BRL). Heterokaryons were obtained as previously
described (Calado et al., 2000). Briefly, 1.5×106 3T3 cells were plated
over subconfluent HeLa cells grown on coverslips on 35×10 mm
tissue culture dishes. 3T3 cells were allowed to adhere for 3 hours at
37°C, 5% CO2, in the presence of 20 µg ml–1 emetine. The cells were
then placed in complete MEM medium with 20 µg ml–1 emetine and
incubated for further 3 hours. To induce cell fusion, coverslips were
rinsed in PBS and placed on a drop of polyethylene-glycol (PEG
1500; Roche Biochemicals, Indianapolis, IN, USA) for 2 minutes. The
coverslips were then washed in PBS and further incubated in culture
medium at 37°C for 4 hours.
To induce segregation of the different nucleolar component,
actinomycin D (Sigma) was added to the tissue culture medium at a
final concentration of 0.07 µg ml–1 1 hour before fixation. To inhibit
nuclear export, leptomycin B (LMB; Sigma) was added at a final
concentration of 50 nM to the tissue culture medium 3 hours before
fixation.
Transfections
Mainly HeLa cells but also COS7 cells were used for transfections
studies. DNA for transfection assays was purified using the Qiagen
plasmid DNA midi-prep kit (Qiagen, Hilden, Germany). HeLa
subconfluent cells grown on glass coverslips in 35×10 mm tissue
culture dishes were transiently transfected with 1 µg of purified
plasmid DNA and using FuGene6 Reagent (Roche Biochemicals,
Indianapolis, IN, USA) according to the manufacturer’s protocol.
Subconfluent COS7 cells seeded in 25 cm3 flasks were transiently
transfected with purified plasmid DNA by mixing with Lipofectamine
(Gibco BRL) according to the manufacturer’s protocol. Cells were
analyzed at 16-24 hours after transfection.
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Western blotting
Western-blot analysis of transfected cells was performed for all
constructs as previously described (Gama-Carvalho et al., 1997) using
whole-cell extracts that were prepared in SDS sample buffer. Lysates
were boiled for 10 minutes prior to fractionation by electrophoresis
in either 10% or 12.5% polyacrylamide gels and transferred to a
PVDF membrane by electroblotting. Anti-His, anti-GFP and anti-
FLAG were used as primary antibodies. Horseradish peroxidase-
conjugated anti-mouse IgG and anti-rabbit IgG (Amersham) were
used as secondary antibodies. Blots were developed with an enhanced
chemiluminescence detection system.
Immunofluorescence and immunoelectron microscopy
Cells on coverslips were briefly rinsed in PBS, fixed in 3.7%
formaldehyde (freshly prepared from paraformaldehyde), diluted in
PBS for 10 minutes at room temperature and washed in PBS. The
cells were then permeabilized with either 0.5% Triton X-100 for 15
minutes or 0.05% SDS for 10 minutes at room temperature and
washed in PBS. Immunofluorescence and confocal microscopy were
performed as described (Calado et al., 2000). For analysis of
hypothalamic neurons, supraoptic nuclei were dissected out of male
3-month-old rats of the Sprague-Dawley strain. Immunofluorescence
and immunoelectron microscopy of tissue samples were performed as
described (Lafarga et al., 1998).
In situ hybridization
GluR-B DNA was obtained by SmaI and XbaI digestion of the GluR-
B/pRK plasmid (Higuchi et al., 1993). This fragment and the plasmid
containing the C-RNA were purified, labeled with digoxigenin –11-
dUTP by nick translation (Lichter et al., 1991) and used as probes for
in situ hybridization. Before in situ hybridization, cells were
immunostained as described with the required antibody and fixed for
10 minutes in 1% formaldehyde. Fixed cells were then washed with
PBS and, immediately before hybridization, were incubated in
hybridization mixture for 5 minutes at 37°C. Cells were hybridized
for 4 hours at 37°C in 50% formamide, 2× SSC, 10% dextran sulfate,
Fig. 1.Subcellular distribution of endogenous ADAR1.
(A) Schematic representation of hADAR1 proteins (150 kDa and 110
kDa forms). The most important domains of hADAR1 are indicated
as follow: ZBDs, Z-DNA-binding domains (light gray); dsRBDs,
double-stranded RNA binding domains (black boxes); deaminase
domain (dark gray box). The partial ADAR1 fragments (black lines)
shown were expressed in E. coliand used for production of rabbit
polyclonal antibodies. Numbers denote amino acid positions relative
to full-length hADAR1. (B) Western-blot analysis of HeLa and
COS7 total cell extracts prepared and fractionated by SDS-PAGE.
Western blotting was then performed with a pre-immune serum (lane 1) and with anti-ADAR1 antibodies: 007 (lane 2) and 668 (lane 3-5).
Extracts of COS7 cells transiently transfected with Flis-ADAR1 (Fig. 2) are shown in lane 5. All antibodies recognized the full-length
hADAR1 (150 kDa) and the 110 kDa form of ADAR1. Molecular weight markers are shown on the left. (C) HeLa cells were immunostained
with antibodies 007 and 668, and with the respective pre-immune sera. The panels are representative of the labeling patterns observed.
(D) Neurosecretory neurons from the supraoptic nucleus were obtained from squash preparations of rat hypothalamus and analysed by indirect
immunofluorescence. The cells were double-labeled with affinity-purified anti-ADAR1 antibody (007) and an anti-histone antibody. The
ADAR1 antibody produces a non-homogeneous nucleoplasmic staining, with additional labeling of the nucleolus (arrow). Within the
nucleoplasm, the antibody decorates nuclear speckles. Bar, 10 µm.
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50 nM sodium phosphate pH 7.0 with probes at 2 ng µl–1. Post-
hybridization washes were in 50% formamide, 2× SSC (three times
for 5 minutes at 45°C) and in 2× SSC (three times for 5 minutes at
45°C). The sites of hybridization were visualized using a cy3 anti-
digoxigenin secondary antibody (Molecular Probes) diluted in 4×
SSC-Tween, 2% bovine serum albumin, 0.2% gelatin.
FRAP and FLIP analysis
Live cells were imaged at 37°C maintained by a heating/cooling
frame (LaCon, Germany) in conjunction with an objective heater
(PeCon, Germany). Images were acquired on a Zeiss LSM 510 with
the Planapochromat 63×/1.4 objective. Enhanced green fluorescence
protein (EGFP) fluorescence was detected using the 488 nm laser line
of an argon laser (25 mW nominal output) in conjunction with a LP
505 filter. Each FRAP (fluorescence recovery after photobleaching)
analysis started with three image scans, followed by a bleach pulse
of 0.5 seconds on a spot with the size of a nucleolus. Single section
images were collected at 3 second intervals. For imaging, the laser
power was attenuated to 0.1-0.2% of the bleach intensity. The
average fluorescence in the nucleus T(t) and the average fluorescence
in the bleached region I(t) were calculated for each background
subtracted image at time t after bleaching. FRAP recovery curves
were normalized according to Phair and Misteli (Phair and Misteli,
2000).
where Ti is the fluorescence in the nucleus before bleaching and I i is
the fluorescence in the bleached region before bleaching. This
normalization corrects for the loss of fluorescence caused by imaging.
Typically, ~10% of the total EGFP fluorescence was lost during the
bleach pulse. During the post-bleaching scanning phase, the
fluorescence lost was <5% for EGFP.
For FLIP (fluorescence loss in photobleaching) experiments, cells
were repeatedly bleached at intervals of 4.5 seconds and imaged
between bleach pulses. Bleaching was performed by 538-millisecond
bleach pulses on a spot with a diameter equivalent to that of a
ucleolus. Repetitive bleach pulses were achieved, taking advantage
of the trigger interface for LSM 510. An electronic oscillator circuit
was built to create pulses with a user-defined frequency. When
connected to the LSM 510, it would then trigger the bleaching events.
A series of 600 images were collected for each cell with laser power
attenuated to 1% of the bleach intensity. Nuclear fluorescence of
selected areas in FLIP experiments was measured using the ROI mean
function of the LSM 510 Physiology Package. The data were then
background subtracted and normalized to correct loss of fluorescence
caused by imaging, in a similar way to FRAP but using an adjacent
cell to estimate T(t) and T0. Loss of fluorescence caused by imaging






Journal of Cell Science 116 (9)
Fig. 2.The full-length (150 kDa)
form of hADAR1 localizes to the
cytoplasm and the short (110 kDa)
form localizes to the nucleolus.
(A) Schematic representation of
differently tagged hADAR1
constructs. In-frame methionines
present in hADAR1 cDNA are shown
(M296, M337). The NLS recently
described by Eckmann et al.
(Eckmann et al., 2001) is marked by
an asterisk (*). (B) HeLa cells were
transiently transfected with the
indicated hADAR1 constructs and
assayed for ADAR1 localization by
either direct detection of GFP or
indirect immunofluorescence using
anti-FLAG and anti-His antibodies.
GFP- and FLAG-tagged ADAR1
localize to the cytoplasm. The anti-
His antibody stains both the
cytoplasm and the nucleolus. In
addition, the anti-His antibody labels
discrete aggregates in the
nucleoplasm (arrow). (C) Western-
blot analysis of total proteins from
COS7 cells transfected with the
indicated plasmids. Total cell extracts
after 36 hours of expression were
prepared and fractionated by SDS-
PAGE. Western blotting was then
performed with an anti-GFP antibody
(lanes 1, 2), an anti-FLAG antibody
(lanes 3, 4) and an anti-His antibody
(lanes 5-7). The western-blot signal
observed with mobility just below
that of the ADAR1 band with the
anti-FLAG antibody is a nonspecific
signal also present in non-transfected cells (Fig. 2C, lanes 3,4). Both antibodies recognize the full-length (150 kDa) hADAR1 but the short (110
kDa) form of the protein is only specifically detected with anti-His antibody. Molecular weight markers are shown on the left.
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Results
hADAR1 localizes in the cytoplasm, nucleoplasm and
nucleoli
ADAR1 is ubiquitously expressed and previous observations
indicated that there are two forms of this enzyme in humans:
a 150 kDa protein (comprising amino acids 1-1226) that is
induced by interferon and localizes predominantly in the
cytoplasm, and a 110 kDa protein (encompassing residues 296-
1226) that is constitutively expressed and localizes to the
nucleus (George and Samuel, 1999a; George and Samuel,
1999b; Patterson and Samuel, 1995). To further characterize
the subcellular distribution of the ADAR1 enzyme, indirect
immunofluorescence microscopy was performed using rabbit
polyclonal antibodies raised against fragments of the human
Fig. 3.hADAR1 shuttles between the cytoplasm and the nucleus and
localizes to the nucleolus with no requirement for the N-terminal
domain. N-terminal and C-terminal deletions of hADAR1 were fused
to GFP. The most important domains of hADAR1 are indicated as
follow: ZBDs, Z-DNA-binding domains (light gray); dsRBDs,
double-stranded RNA binding domains (black boxes); deaminase
domain (dark gray box). Numbers denote amino-acid positions
relative to the N-terminus of hADAR1. HeLa cells were transfected
with the indicated constructs and, approximately 18 hours after
transfection, the cells were incubated with or without 50 nM LMB
for 3 hours, fixed and observed directly with the fluorescence
microscope. Notice that the cytoplasmic chimera resulting from the
C-terminal deletion (C) accumulates in the nucleus with nucleolar
exclusion after LMB treatment (D), whereas the full-length fusion
protein (A) is concentrated in the nucleolus after LMB treatment (B).
HeLa cells transfected with GFP-ADAR1C-Term were fused with
murine 3T3 cells to form heterokaryons. These cells were treated
with a protein synthesis inhibitor (emetine, 20 µg ml–1) for 3 hours
before fusion. After fusion, the cells were kept in culture for 3 hours
in the presence of emetine. Heterokaryons were fixed and labeled
with monoclonal antibody 4F4 directed against hnRNP C protein,
which does not shuttle. Like hnRNP C (F), the N-terminal deletion of
hADAR1 remains restricted to the transfected HeLa cell nucleus (E).
The dashed lines in E and F indicate the contour of the murine
nucleus in the heterokaryon. Notice that the N-terminal deletion of
ADAR1 localizes exclusively to nucleoli (E). Bar, 10 µm.
Fig. 4.Subcellular distribution of endogenous ADAR2. Schematic
diagram comparing hADAR1 and hADAR2. The numbers indicated
at the C-terminus represent size of the protein in amino acids. The
most important domains of hADAR1 are indicated as follow: ZBDs,
Z-DNA-binding domains (light gray); dsRBDs, double-stranded
RNA binding domains (black boxes); deaminase domain (dark gray
box). (A) HeLa cells were immunolabeled with anti-ADAR2
antibody. The labeling pattern is diffuse throughout the nucleoplasm,
with concentration in nucleoli. The relative concentration of ADAR2
staining in the nucleolus varies from cell to cell. (B) A western-blot
analysis of total (T) and nuclear (N) HeLa cell extracts. Cell extracts
were prepared and fractionated by SDS-PAGE. Western blotting was
then performed with anti-ADAR2 antibody (Ab 70). Extracts of
HeLa cells transiently transfected with FlisADAR2 are shown in lane
3. Molecular weight markers are shown on the left.
(C,D) Cryosections of neurosecretory neurons from the hypothalamic
supraoptic nucleus were double-labeled with antibodies directed
against fibrillarin (C) and ADAR2 (D). ADAR2 is predominantly
detected in nucleoli, which can be readily identified by the fibrillarin
staining. Bar, 10 µm.
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protein (hADAR1) expressed in Escherichia coli. A schematic
representation of hADAR1 forms and the different segments
used for production of antibodies is shown in Fig. 1A. Ab 007
was raised against the region encompassing amino acids 167-
359, which corresponds to the ZBDs, and Ab 668 was raised
against the first two dsRBDs (amino acids 504-640). Western-
blot analysis of HeLa and COS7 total cell extracts shows that
both antibodies recognize two polypeptides of 150 kDa and
110 kDa (Fig. 1B, lanes 2-4), whereas the pre-immune serum
is devoid of any reactivity (Fig. 1B, lane 1). For comparison,
COS7 cells were transiently transfected with a plasmid
containing the full-length hADAR1 cDNA tagged with both a
Flag epitope and a histidine hexamer (Flis-ADAR1; Fig. 2).
Total protein extracts from the transfected cells were probed
with Ab 668 and the results confirm that the 150 kDa and 110
kDa protein bands correspond to the long and short forms of
hADAR1 (Fig. 1B, lane 5).
Immunofluorescence analysis of HeLa cells incubated with
antibodies 007 and 668 reveals predominant labeling of the cell
nucleus with additional staining of the cytoplasm (Fig. 1C).
Within the nucleus, there is an intense nucleoplasmic staining
with additional, albeit weaker, labeling of nucleoli. The
nucleoplasmic labeling is not homogeneous, with a higher
concentration in nuclear speckles, as confirmed by double-
labeling experiments using antibodies directed against
spliceosome components (data not shown). The intensity of
nucleolar staining varies from cell to cell. Similar
immunofluorescence results were observed in HeLa and COS7
cells (data not shown).
Because most of the known ADAR-edited transcripts in
mammals are expressed in the central nervous system (Gott and
Emeson, 2000; Palladino et al., 2000; Patton et al., 1997), we
decided to examine the distribution pattern of ADAR1 in
sections of rat brain. Consistent with the data observed in
cultured cell lines, the Ab 007 labels predominantly the
nucleus of hypothalamic neurons (Fig. 1D). Although the
labeling is more prominent in the nucleoplasm, the antibody
also stains the nucleolus (Fig. 1D, arrow). Thus, ADAR1
appears to be distributed throughout the cytoplasm and the
nucleus, including the nucleolus.
To verify the localization of endogenous ADAR1 observed
by immunofluorescence, we next analysed the distribution of
tagged versions of ADAR1. Two different constructs were
generated using the full-length hADAR1 cDNA. One construct
encodes hADAR1 tagged with GFP at the N-terminus (GFP-
ADAR1). The other encodes hADAR1 tagged simultaneously
with a N-terminal Flag epitope and a C-terminal histidine
hexamer (Flis-ADAR1) (Fig. 2A).
When HeLa cells were transfected with GFP-ADAR1 and
directly observed in the fluorescence microscope, the labeling
was exclusively detected in the cytoplasm (Fig. 2B). Western-
blot analysis of total protein extracts from untransfected and
transfected cells probed with anti-GFP antibodies (Fig. 2C,
lanes 1, 2) shows a single band of ~180 kDa, which
corresponds to the expected molecular weight of the full-length
ADAR1 (150 kDa) fused to GFP (27 kDa). The localization of
full-length ADAR1 to the cytoplasm is consistent with the
presence of a nuclear export signal (NES) at the N-terminus of
the protein (amino acids 125-137) (Eckmann et al., 2001).
Next, HeLa and COS7 cells were transfected with Flis-
ADAR1 and probed with anti-Flag and anti-His antibodies. By
western blot, the anti-Flag antibody reacts with the full-length
form of ADAR1 (Fig. 2C, lane 4), whereas the anti-His
antibody reveals both the full-length (150 kDa) and the shorter
(110 kDa) forms of the protein (Fig. 2C, lane 7). The same two
protein bands are detected when total protein extracts from
cells transfected with Flis-ADAR1 are probed with anti-
ADAR1 antibody (Fig. 1B, lane 5). The shorter form of
ADAR1 was previously suggested to result from a proteolytic
cleavage of the N-terminus of the full-length protein (Patterson
and Samuel, 1995). Nevertheless, the presence of an in-frame
methionine precisely at residue 296 raises the possibility of
alternative starting sites being used by the translation
machinery. Because ADAR1 contains a further in-frame
methionine at residue 337, we generated a Flag/His tagged
hADAR1 construct with methionine 296 mutated to an alanine
(M296A). When this construct was transfected into either
HeLa or COS7 cells, a protein band with slightly higher
mobility was observed by western blotting with the anti-His
antibody (Fig. 2C, lane 6, arrowhead). The appearance of this
shorter protein product corresponding to a polypeptide starting
at methionine 337 supports the view that synthesis of the
150 kDa and 110 kDa forms of ADAR1 can be caused by
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Fig. 5.Electron microscopy reveals that ADAR2 localizes in a novel
subnucleolar compartment. Ultrathin sections from rat brain neurons
were immunogold labeled with antibodies directed against ADAR2
and fibrillarin. The ADAR2-specific gold particles decorate the
periphery of the fibrillar component (f) and are largely excluded from
the fibrillar centers (fc) and the granular component (g). By contrast,
the anti-fibrillarin antibody produces an intense labeling of the dense
fibrillar component. Bar, 300 nm.
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alternative usage of either M1 or M296 as starting methionines.
However, we cannot exclude the possibility that a proteolytic
event is taking place in parallel.
When double-immunofluorescence experiments were
performed on cells transfected with Flis-ADAR1, the anti-Flag
antibody produced exclusive staining of the cytoplasm,
whereas the anti-His antibody labeled both the cytoplasm and
the nucleus, with prominent staining of nucleoli (Fig. 2B).
Staining of the cytoplasm and nucleoli was similarly observed
when cells transfected with Flis-ADAR1 were incubated with
anti-ADAR1 antibody 668 (data not shown). These results
suggest that anti-FLAG antibody detects exclusively the 150
kDa protein (which localizes to the cytoplasm), whereas anti-
His antibody reacts with both the 150 kDa and the 110 kDa
proteins (which localize to the nucleolus). Interestingly,
overexpression of exogenous ADAR1 leads to the appearance
of discrete aggregates in the nucleoplasm that are reminiscent
of nuclear speckles (Fig. 2B arrow, and data not shown).
However, double-labeling experiments using antibodies
against splicing factors show that these structures are distinct
from the nuclear speckles where spliceosomal components
accumulate (data not shown).
In conclusion, the data show that endogenous hADAR1 in
HeLa and COS7 cells is present in two distinct forms of 150
and 110 kDa. The same two proteins are produced by transient
transfection of the full-length hADAR1 cDNA, presumably
owing to alternative usage of starting methionines. The long
form of ADAR1 enzyme localizes predominantly to the
ytoplasm, whereas the short form is nuclear and accumulates
in the nucleolus. The results obtained with epitope-tagged
proteins are consistent with the immunofluorescence analysis
that reveals the presence of endogenous ADAR1 in the
cytoplasm, nucleoplasm and nucleolus.
The C-terminal region of hADAR1 targets it to the
nucleolus
Recent studies have shown that hADAR1 shuttles between the
nucleus and the cytoplasm and contains a CRM1-dependent
nuclear export signal in its N-terminus (Poulsen et al., 2001).
Although putative nuclear localization signals (NLSs) have
been predicted by sequence analysis in the same region of the
protein, these are not biologically active. Instead, an NLS that
overlaps with the third dsRNA-binding domain is responsible
for nuclear import of the protein (Eckmann et al., 2001). Our
observation that both endogenous and transfected hADAR1 are
present in the nucleolus leads us to investigate which domains
of the protein are responsible for the nucleolar targeting.
First, we asked whether the full-length protein, which (at
steady state) localizes predominantly to the cytoplasm but is
constantly shuttling to the nucleus, can be targeted to the
nucleolus. To address this question, HeLa cells were
transfected with GFP-tagged full-length hADAR1 and treated
with LMB, a specific inhibitor of the CRM1 export receptor.
Fig. 6.hADAR1 and hADAR2 co-
localize within the nucleolus. HeLa
cells were transfected with GFP-
ADAR2, incubated in the absence
(A) or in the presence (B) of
actinomycin D (0.07 µg ml–1) for 1
hour and double-labeled with a
monoclonal antibody against
fibrillarin. The merged images show
clearly that GFP-ADAR2 (green) and
fibrillarin (red) do not co-localize.
(C) HeLa cells were co-transfected
with GFP-ADAR2 and Flis-ADAR1C-
Term (Fig. 2A). Approximately 16
hours after transfection, cells were
fixed, immunostained with anti-FLAG
antibody (red) and analysed by
confocal microscopy. GFP-ADAR2
and Flis-ADAR1 co-localize in the
nucleolus of co-transfected cells, as
can be seen in the merged image
(yellow). Images from the same
microscopic fields are shown side by
side. The dashed lines indicate the
contour of the HeLa cell nucleus. Bar,
10 µm.
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LMB treatment induced accumulation of GFP-hADAR1 in the
nucleus as previously described (Eckmann et al., 2001; Poulsen
et al., 2001), with clear concentration in nucleoli in most of the
cells (Fig. 3A,B). Next, two GFP-tagged deletions of hADAR1
were constructed and their localization analysed. As expected,
the GFP fusion with the N-terminal region of hADAR1 (GFP-
ADAR1N-Term), which contains a functional NES (Poulsen et
al., 2001), is exclusively detected in the cytoplasm (Fig. 3C).
By contrast, the C-terminal region of hADAR1, which harbors
a NLS in the third dsRBD, accumulates exclusively in
nucleolus (Fig. 3E). When cells transfected with the N-terminal
version of hADAR1 are treated with LMB, the protein
accumulates in the nucleoplasm (Fig. 3D), indicating the
presence of an additional functional NLS in the N-terminus as
previously reported (Poulsen et al., 2001). This protein is
completely excluded from the nucleolus, showing that the
nucleolar targeting signal is contained in the C-terminal region
of hADAR1.
Following the observation that the N-terminus of hADAR1
harbors an NLS, we asked whether an additional NES is
present in the C-terminal region. An interspecies heterokaryon
assay was therefore performed to determine whether GFP-
ADAR1C-Term is a shuttling protein. The distribution of
GFP-ADAR1C-Term was monitored in human-mouse
heterokaryons produced by polyethylene-glycol-induced
fusion of HeLa and murine NIH 3T3 cells (Calado et al., 2000).
Heterokaryons were kept in culture for up to 6 hours in
the presence of the protein-synthesis inhibitor emetine. As
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Fig. 7.hADAR2 does not shuttle and
an N-terminal domain is responsible for
its nuclear localization. (A) Schematic
representation of the GFP-tagged full-
length hADAR2 and the GFP-ADAR2
deletions constructed to study putative
localization signals in hADAR2.
Numbers denote amino acid positions
relative to the N-terminus of hADAR2.
Asterisks indicate putative NLSs
identified by sequence analysis, and the
respective amino acid sequences are
shown. (B) HeLa cells were transiently
transfected with the indicated GFP-
ADAR2 constructs. Approximately 16
hours after transfection, cells were
fixed and directly observed with the
fluorescence microscope. (C) HeLa
cells were transfected with GFP-
ADAR2 and fused with murine NIH
3T3 cells. The heterokaryons were
incubated in the presence of emetine.
Immunostaining with anti-hnRNP C
was used as control. Both GFP-ADAR2
and hnRNP C molecules remain
restricted to the transfected HeLa
nucleus. The dashed lines indicate the
contour of the murine nucleus in the
heterokaryon. Incubation of HeLa cells
expressing GFP-ADAR2 at 4°C in the
presence of emetine shows that the
protein does not leak to the cytoplasm.
Bar, 10 µm.
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controls, heterokaryons were labeled with monoclonal
antibodies specific for human hnRNP C (a protein that does
not shuttle) and hnRNP A (a protein that shuttles constantly
between the nucleus and the cytoplasm) (Pinol-Roma and
Dreyfuss, 1992). In the presence of emetine, both human hRNP
C (Fig. 3F) and GFP-ADAR1C-Term (Fig. 3E) remain
restricted to the human nucleus, demonstrating the inability of
the hADAR1C-Term to shuttle. Under the same conditions, the
shuttling protein hnRNP A was readily detected in the murine
nucleus (data not shown).
In summary, these data confirm the presence of an NLS
within the N-terminus of hADAR1, and show that the C-
terminal region of the protein encompassing amino acids 443-
1226 harbors a nucleolar targeting signal.
hADAR2 and hADAR1 co-localize within the nucleolus
Given the high homology between the C-terminal region of
hADAR1 and human ADAR2 (hADAR2) (Fig. 4), we next
analysed the cellular distribution of hADAR2. Indirect
immunofluorescence was performed in HeLa cells using a
specific anti-ADAR2 antibody (O’Connell et al., 1997). The
results show that ADAR2 is nucleoplasmic and highly enriched
in nucleoli in a large proportion of cells (Fig. 4A). Western-
blot analysis confirms that the antibody reacts with a specific
protein band in cells transfected with full-length ADAR2
cDNA (Fig. 4B, Flis-ADAR2). The results further reveal a very
low abundance of endogenous ADAR2 in total HeLa cell
extracts, with a significant concentration of the protein in the
nuclear fraction (Fig. 4B).
Next, the anti-ADAR2 antibody was used to perform
immunofluorescence in brain tissue, where the enzyme is
expressed at higher level (Gerber et al., 1997). As shown in
Fig. 4C,D, ADAR2 is predominantly localized to nucleoli of
neurons from the hypothalamic supra-optic nucleus. To further
characterize the subnucleolar localization of ADAR2,
immunoelectron microscopy was performed on rat
hypothalamic neurons. As shown in Fig. 5, the immunogold
particles tend to cluster at the periphery of the dense fibrillar
component, showing no obvious association with either
fibrillar centers or granular regions. To extend these
observations, HeLa cells were transfected with a plasmid
encoding GFP-ADAR2 and immunostained with anti-
fibrillarin antibody, which is a marker for the dense fibrillar
component. Clearly, GFP-ADAR2 and fibrillarin do not co-
localize in the nucleolus (Fig. 6A). The spatial separation
between ADAR2 and fibrillarin is even more evident following
treatment of cells with actinomycin D, which causes
segregation of the different nucleolar components (Fig. 6B).
Lack of co-localization was further observed between GFP-
ADAR2 and markers for the fibrillar center and the granular
component (data not shown).
Taken together, our results show that ADAR2 is localized to
a specific subnucleolar compartment. This was confirmed by
analysing the distribution of both endogenous ADAR2 in
hypothalamic neurons (by electron microscopy) and GFP-
tagged hADAR2 transiently expressed in HeLa cells.
Given that hADAR1 is also present in the nucleolus, we
thought to compare the subnucleolar distribution of both
editing enzymes. Treatment with LMB causes full-length GFP-
ADAR1 to accumulate in the nucleolus (Fig. 3B), where it
localizes with Flis-ADAR1C-Term (data not shown). We then
co-transfected HeLa cells with GFP-ADAR2 and Flis-
ADAR1C-Term. The staining of hADAR2 (Fig. 6C, green) and
hADAR1C-Term (Fig. 6C, red) revealed almost identical
patterns of nucleolar localization, as confirmed by merging the
green and red images (Fig. 6C, merged). We therefore conclude
that ADAR1 and ADAR2 localize to the same subnucleolar
compartment.
Identification of hADAR2 nuclear and nucleolar
localization signals
Having established that ADAR2 and the C-terminal region of
ADAR1 are predominantly localized in nucleoli, we next
compared the sequences of the two proteins. Sequence
alignments of the hADAR1 NLS (Eckmann et al., 2001) with
human and rat ADAR2 enzymes revealed that this region is not
conserved (data not shown). Sequence analyses of hADAR2
yielded various putative NLSs in the N-terminus of the protein
Fig. 8.hADAT1 is a nucleocytoplasmic shuttling
protein that is excluded from the nucleolus.
Schematic representation of the homology
between hADAR1, hADAR2 and hADAT1. The
three enzymes contain a deaminase domain and
only hADAT1 does not contain dsRNA-binding
domains. The most important domains of
hADAR1 are indicated as follow: ZBDs, Z-DNA-
binding domains (light gray); dsRBDs, double-
stranded RNA binding domains (black boxes);
deaminase domain (dark gray box). The size of
the proteins are indicated at their C-termini as the
number of amino acids. HeLa cells were
transfected with GFP-ADAT1 and fused with
murine NIH 3T3 cells. The heterokaryons were
incubated in the presence of emetine.
Immunostaining with anti-hnRNP C was used as
control. In contrast to hnRNP C, which remains
restricted to the transfected HeLa nucleus, GFP-ADAT1 migrates to the murine nuclei. The dashed lines indicate the contour of the murine
nuclei in the heterokaryon. Incubation of HeLa cells expressing GFP-ADAT1 at 4°C in the presence of emetine shows that the protein does not
leak to the cytoplasm. Bar, 10 µm.
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(amino acids 1-139) and two putative NLSs in the C-terminus
(Fig. 7A). To try to identify the signal responsible for the
observed nuclear and nucleolar localization, we produced
deletion variants of hADAR2 fused to GFP at the N-terminus
(Fig. 7A). The truncated versions of the protein were
transiently transfected in HeLa cells and the localization
analysed by confocal microscopy (Fig. 7B). HeLa cell extracts
transfected with the different deletions were analysed by
western blotting with an anti-GFP antibody and protein bands
of the expected molecular mass were detected (data not
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Fig. 9.Endogenous hADAR1 and hADAR2 are
excluded from the nucleolus of cells expressing an
editing substrate. HeLa cells were transiently
transfected with a plasmid containing either the
editing-competent murine GluR-B gene portion
(Minigene B13) or a control gene portion from the
Friends virus genome (C-RNA). Endogenous
localization of editing enzymes was monitored by
indirect immunofluorescence microscopy with
antibodies directed against ADAR2 (b,e,n) and
ADAR1 (Ab 668) (h). Alternatively, cells were
transfected with a plasmid encoding GFP-ADAR2
(l). GluR-B- and C-RNA-transcribing cells were
visualized by fluorescent in situ hybridization with a
GluR-B (a,d,g,j,p) or C-RNA (m) probe labeled with
digoxigenin. The hybridization sites were detected
using a cy3 anti-digoxigenin secondary antibody. The
GluR-B and C-RNA transcripts were detected ~40
hours after transfection. The GluR-B probe produces
mainly a nucleoplasmic staining pattern, with
nucleolar exclusion (a,d,g,j,p). In addition, transcripts
tend to accumulate in discrete nucleoplasmic regions
(d,g,j,p). In GluR-B-transcribing cells, ADAR2 and
ADAR1 become completely excluded from the
nucleolus (b,e,h,l). For comparison, cells that do not
express GluR-B are shown in b (left side), h (inset)
and l (inset). (e,h,l) Recruitment of ADAR1 and
ADAR2 to the nucleoplasmic regions where GluR-B
transcripts accumulate. In contrast to cells expressing
GluR-B, ADAR2 persists concentrated in the
nucleolus of cells expressing C-RNA (m-o).
Furthermore, in contrast to ADAR1 and ADAR2, the
nucleolar protein B23 remains in the nucleolus of
cells expressing GluR-B transcripts (p-r). (c,f,i,k,o,r)
A superimposition of the corresponding double-
labeled images. Bar, 10 µm.
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shown). GFP-∆N localizes almost exclusively to the
cytoplasm, whereas GFP fused to the first N-terminal 139
amino acids is primarily nuclear. This strongly suggests the
presence of an active NLS in the N-terminal region, but only
if the protein is devoid of an NES. Otherwise the cytoplasmic
localization could be the result of a dominant export activity,
as observed for full-length ADAR1 (Fig. 3A,B). To address this
question, we treated the transfected cells with LMB (data not
shown). After 5 hours of LMB treatment, the distribution of
GFP-∆N remained cytoplasmic, excluding the presence of
a CRM1-dependent NES. Furthermore, ADAR2 remains
restricted to the HeLa nucleus in an interspecies heterokaryon
(Fig. 7C), indicating that the protein is devoid of any type of
NES.
Surprisingly, deletion of a putative N-terminal NLS or
stretches of basic amino acids (∆64-75 and ∆64-132) had no
effect on the nuclear accumulation of the protein, suggesting
that hADAR2 contains a non-canonical NLS. Deletion of
amino acid residues 64-75 (GFP∆64-75) does not affect
nucleolar localization, whereas deletion of residues 64-132
(GFP∆64-132), which removes the first dsRBD, results in a
protein that, although nuclear, is no longer able to concentrate
in the nucleolus. Thus, the region between residues 75 and 132
is required for nucleolar targeting. Nevertheless, this stretch of
Fig. 10.FRAP and FLIP analysis of GFP-ADAR2 and GFP-ADAR1C-Term. (A) HeLa cells expressing either GFP-ADAR2 or GFP-ADAR1C-
Term were bleached in a selected nucleolus for 0.5 seconds. Images were taken before bleaching and at the indicated time points af er the e d
of the bleach pulse. (B) HeLa cells expressing either GFP-ADAR2 or GFP-ADAR1C-Term were repeatedly bleached in a selected nucleolus at
intervals of 4.5 seconds. Images were taken before bleaching and at the indicated time points after the end of the first bleach pul e. The
bleached nucleolus is indicated by an arrow in the pre-bleached panels. The dashed lines indicate the contour of the HeLa cell nucl us.
Corresponding quantitative data of fluorescence-recovery kinetics are plotted on the right-hand side of each set of images. For FRAP
experiments (A), the fluorescence intensity in the bleached region was measured and expressed as a relative fluorescence recovery ( ormalized
fluorescence; see Materials and Methods). For FLIP experiments (B), the fluorescence intensity was measured in an adjacent nucleolus (marked
by a white circle) and normalized as in FRAP experiments. Bar, 10 µm.
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amino acids is not sufficient to target a GFP fusion to
the nucleolus (see GFP-N1), suggesting that the correct
localization of ADAR2 involves either a bipartite signal or a
signal that is contiguous with sequences beyond amino acid
132.
In summary, the data show that ADAR2 is devoid of any
NES, contains a non-canonical NLS within the first 64 amino
acid residues and harbors a region between residues 75 and 132
that is necessary but not sufficient for nucleolar targeting.
Human cells express a third type of editing enzyme, hADAT,
which shares homology with the C-terminus of hADAR1 and
hADAR2 but lacks dsRBDs (Fig. 8). Unlike ADAR1 and
ADAR2, which modify adenosines present in dsRNA and pre-
mRNA, ADAT acts on tRNA (Maas et al., 1999). To analyse
the cellular distribution of hADAT1, we fused GFP to the
N-terminus of hADAT1. This chimera is detected in the
nucleoplasm, with no nucleolar accumulation (Fig. 8). Thus,
in contrast to hADAR1 and hADAR2, hADAT1 lacks a
nucleolar targeting sequence. To investigate whether hADAT1
is permanently retained in the nucleus or shuttles between the
nucleus and the cytoplasm, we made use of heterokaryons
produced by fusion of HeLa cells transfected with GFP-
ADAT1 and murine 3T3 cells (Fig. 8). The results show that
GFP-ADAT1 molecules migrate from the transfected HeLa
nucleus to the murine nuclei, implying that they are exported
from the nucleus to the cytoplasm. Given the size of GFP-
ADAT1 (82 kDa), this could be result of passive leakage
through the pores. To distinguish between receptor-mediated
transport and passive diffusion, HeLa cells expressing GFP-
ADAT1 were transferred to 4°C in the presence of a protein-
synthesis inhibitor. Receptor-mediated nuclear import and
export are energy-dependent processes that are blocked at low
temperature, whereas diffusion is unaffected (Michael et al.,
1995). GFP-ADAT1 remains exclusively localized in the
nucleus of HeLa cells incubated at 4°C (Fig. 8), indicating that
GFP-ADAT1 does not diffuse passively to the cytoplasm. This
suggests that, like hADAR1, hADAT1 shuttles across the
nuclear pores, making use of a receptor-mediated export
pathway. However, in striking contrast to hADAR1 and
hADAR2, hADAT1 does not accumulate in the nucleolus.
Expression of an editing substrate delocalizes
endogenous ADAR1 and ADAR2 from the nucleolus
To investigate whether the nucleolus represents a major editing
site in the nucleus, we next examined the subcellular
localization of an RNA that is known to be edited by both
hADAR1 and hADAR2 (Dabiri et al., 1996; Hurst et al., 1995).
HeLa cells were transiently transfected with a plasmid
containing the editing-competent murine glutamate receptor
GluR-B gene portion (B13 Minigene), which comprises both
the Q/R site that is edited by ADAR2 and the hotspot-1 site in
the intron that is edited by ADAR1 (Higuchi et al., 1993). Both
enzymes are very specific and do not compete for editing a
particular site. Fluorescent in situ hybridization using a GluR-
B probe shows that GluR-B transcripts are present mainly in
the nucleus. Within the nucleus, the GluR-B transcripts are
non-homogeneously distributed in the nucleoplasm with clear
nucleolar exclusion (Fig. 9a,d,g,j,p, red). Double-labeling
experiments using anti-ADAR2 (Ab 70) and anti-ADAR1 (Ab
668) antibodies show that, in cells expressing the editing
substrate, both enzymes become excluded from the nucleolus
and co-localize precisely with the GluR-B transcripts in the
nucleoplasm (Fig. 9b,e,h, green). Similar results were obtained
with exogenously expressed GFP-ADAR2 and GFP-
ADAR1C-Term (Fig. 9l, green, and data not shown). De-
localization of ADAR1 and ADAR2 from the nucleolus was
not observed in cells expressing transcripts from a plasmid that
contains part of the Friend virus genome (Fig. 9m-o and data
not shown). Recruitment of ADAR1 and ADAR2 from the
nucleolus to the nucleoplasm of cells expressing GluR-B was
further shown to be specific for editing enzymes, because the
distribution of nucleolar components such as the protein B23
remains unaffected (Fig. 9p-r).
Taken together these results suggest that, although ADAR1
and ADAR2 localize to the nucleolus, editing substrates do not
appear to be recruited there in order to be edited. Rather, the
editing enzymes become excluded from the nucleolus when
substrate pre-mRNAs are transcribed in the nucleoplasm. This
suggests that the localization of ADAR1 and ADAR2 in the
nucleolus is transient and most likely dynamic.
To examine the dynamic association of ADAR enzymes with
the nucleolus in the living cell nucleus, we performed
photobleaching experiments (FRAP and FLIP) using HeLa
cells transfected with either GFP-ADAR2 or GFP-ADAR1C-
Term. The vast majority of transfected HeLa cells contain
several GFP-labeled nucleoli per nucleus. Using a high-
powered spot laser pulse, the entire fluorescence associated
with one nucleolus was bleached irreversibly. Then, in FRAP
experiments the recovery of fluorescence signal in the bleached
nucleolus was recorded by time-lapse imaging (Fig. 10A). The
results show that the fluorescence produced by GFP-ADAR2
and GFP-ADAR1C-Term recovers within a few minutes after
the bleach, indicating that unbleached GFP-fusion molecules
have moved from the nucleoplasm into the bleached nucleolus.
Because little fluorescence is visible in the nucleoplasm of
these cells, it is most likely that the GFP-fusion molecules are
in dynamic equilibrium between unbleached nucleoli and
nucleoplasm. To confirm this result, FLIP experiments were
performed (Fig. 10B). Bleaching over time of a single
nucleolus eliminated the fluorescence in the other nucleoli,
indicating that all fluorescent GFP-ADAR2 and GFP-
ADAR1C-Term must be exchanging between the different
nucleoli through the nucleoplasm. The results observed in
FLIP are consistent with the FRAP experiments, showing
a faster dynamics of GFP-ADAR2 compared with GFP-
ADAR1C-Term. Overall, the data from photobleaching
experiments suggest that in the living cell, ADAR1 and
ADAR2 are constantly shuttling in and out of the nucleolus.
Discussion
In the present work, we have studied the subcellular
localization of ADAR1 and ADAR2, the editing enzymes that
deaminate adenosine to inosine in long dsRNA duplexes and
specific pre-mRNA transcripts. Immunofluorescence analysis
revealed that endogenous ADAR2 localizes to the nucleus
and nucleolus, whereas ADAR1 distributes throughout the
cytoplasm, nucleoplasm and nucleolus.
Several lines of evidence indicate the presence of short and
long forms of ADAR1 in human cells. The long form of
hADAR1 (150 kDa) localizes to the cytoplasm, is induced by
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interferon and is thought to play a role in antiviral response
mechanisms (Scadden and Smith, 2001). The shorter form (110
kDa) is exclusively nuclear because it lacks an NES present in
the N-terminus of the full-length protein (Poulsen et al., 2001).
Both forms are enzymatically active and it has been previously
proposed that the nuclear 110 kDa version of hADAR1
represents a proteolytic cleavage fragment of the full-length
protein (Patterson and Samuel, 1995). However, the data
presented here argue that a mechanism of alternative usage of
starting methionines can also occur in cells. Our data further
show that both forms of hADAR1 accumulate in the nucleolus.
The shorter form (110 kDa) localizes constitutively to the
nucleolus (Fig. 2B), whereas the full-length form can only be
detected in this compartment after inhibition of nuclear export
(Fig. 3B).
Within the nucleolus, both ADAR2 and ADAR1C-Term
are excluded from the fibrillar centers, the dense fibrillar
component and the granular component. This represents
the first evidence that editing enzymes occupy a novel
subnucleolar compartment, raising the question of whether the
nucleolus contains specific sites dedicated to RNA editing.
Although some nucleolar localization signals have been
identified in proteins such HIV Tat and rev, mdm2, coilin, and
ING1, it is currently accepted that there are no conserved
nucleolar localization signals shared between nucleolar
proteins (Andersen et al., 2002; Lyon and Lamond, 2000). One
possibility is that proteins are not specifically targeted to the
nucleolus but are instead retained within this compartment as
a consequence of interactions with nucleolar components.
Because the nucleolus is highly enriched in small nucleolar
RNAs (snoRNAs) that form dsRNA structures with specific
substrate rRNAs, and in small nuclear RNAs, it is conceivable
that ADAR1 and ADAR2 localize to the nucleolus because
they bind to these abundant dsRNAs. Consistent with this view,
hADAT1 (which lacks dsRBDs) and the ADAR2 ∆64-132
mutant (which lacks the first dsRBD) do not accumulate in the
nucleolus (Fig. 6B, Fig. 8).
Only a few physiological substrates for editing by ADAR1
and ADAR2 are known to date, and none has been localized
to the nucleolus. Because the A-to-I RNA-editing mechanism
requires a crucial dsRNA structure formed around editing sites
(Smith et al., 1997), it is possible that some snoRNAs are
potential substrates for editing. In this context, it is worth
noting that a brain-specific snoRNA (mouse MBII-52 and its
human ortholog HBII-52) has been identified that contains a
guide region with an 18-nucleotide phylogenetically conserved
complementarity to the serotonin receptor 5-HT2C mRNA in a
region containing two out of the four sites of adenosine-to-
inosine editing within the serotonin receptor mRNA (Burns et
al., 1997; Cavaille et al., 2000). Based on this finding, one
could speculate that specific pre-mRNA substrates are targeted
to the nucleolus in order to be edited, a view supported by the
observation that some pre-mRNAs might transiently localize
to the nucleolus before being exported to the cytoplasm (Bains
et al., 1997; Bond and Wold, 1993; Pederson and Politz, 2000).
To test the hypothesis that pre-mRNA substrates are
recruited to the nucleolus to be edited, we expressed the editing
competent portion of glutamate receptor GluR-B pre-mRNA in
HeLa cells (Higuchi et al., 1993). The results show that GluR-
B transcripts accumulate in the nucleoplasm but are never
detected in the nucleolus. Most importantly, both ADAR2 and
ADAR1 become excluded from the nucleolus and accumulate
at nucleoplasmic sites containing GluR-B transcripts. Thus, it
appears that editing enzymes leave the nucleolus and are
recruited to pre-mRNA substrates present in the nucleoplasm.
Consistent with this view, we observe by photobleaching that
ADAR1 and ADAR2 are constantly moving in and out of the
nucleolus in the living cell.
In conclusion, the data suggest that, in living cells, editing
might be regulated by the intracellular compartmentalization
of editing enzymes. ADAR2 shuttles between the nucleolus
and the nucleoplasm, whereas ADAR1 shuttles between the
nucleolus, the nucleoplasm and the cytoplasm. During this
flux, the enzymes might alternatively be recruited onto specific
editing substrates present either in the nucleoplasm or in the
cytoplasm, or be sequestered in the nucleolus. 
We gratefully acknowledge Walter Keller (Biozentrum Basel,
Switzerland) for kindly providing anti-ADAR1 and anti-ADAR2
antibodies, and Peter Seeburg (Max Planck Institute, Heidelberg) for
the GluR-B/pRK plasmid. We are also grateful to our colleagues José
Braga and José Rino for help with photobleaching experiments. We
further thank Inês Condado, Maria do Carmo Silva and Helena Pina
for technical support. This study was supported by grants from
Fundação para a Ciência e Tecnologia, Portugal, and the European
Commission (QLG2-CT-2001-01554). This work was also supported
by the MRC, a grant from the British Heart Foundation (PG/98086),
Ministerio de Ciencia y Tecnologia of Spain (BFI2002-00454) and
Fundación Marqués de Valdecilla’ of Santander, Spain (A05/02).
J.M.P.D. was supported by a long-term fellowship of the European
Molecular Biology Organization (EMBO-ALTF 239-2000).
References
Andersen, J. S., Lyon, C. E., Fox, A. H., Leung, A. K., Lam, Y. W., Steen,
H., Mann, M. and Lamond, A. I. (2002). Directed proteomic analysis of
the human nucleolus. Curr. Biol. 12, 1-11.
Bains, M. A., Giles, I. and Wright, D. H. (1997). Distribution and
configuration of c-myc RNA during transcriptional attenuation in
differentiating cells in-situ. Histochem. Cell. Biol. 107, 259-263.
Basilio, C., Wahba, A. J., Lengyel, P., Speyer, J. F. and Ochoa, S. (1962).
Synthetic polynucleotides and the amino acid code. Proc. Natl. Acad. Sci.
USA48, 613-616.
Bond, V. C. and Wold, B. (1993). Nucleolar localization of myc transcripts.
Mol. Cell. Biol. 13, 3221-3230.
Burd, C. G. and Dreyfuss, G. (1994). RNA binding specificity of hnRNP A1:
significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing.
EMBO J.13, 1197-1204.
Burns, C. M., Chu, H., Rueter, S. M., Hutchinson, L. K., Canton, H.,
Sanders-Bush, E. and Emeson, R. B. (1997). Regulation of serotonin-2C
receptor G-protein coupling by RNA editing. Nature387, 303-308.
Calado, A., Kutay, U., Kuhn, U., Wahle, E. and Carmo-Fonseca, M. (2000).
Deciphering the cellular pathway for transport of poly(A)-binding protein
II. RNA6, 245-256.
Cavaille, J., Buiting, K., Kiefmann, M., Lalande, M., Brannan, C. I.,
Horsthemke, B., Bachellerie, J. P., Brosius, J. and Huttenhofer, A.
(2000). Identification of brain-specific and imprinted small nucleolar RNA
genes exhibiting an unusual genomic organization. Proc. Natl. Acad. Sci.
USA97, 14311-14316.
Chen, C. X., Cho, D. S., Wang, Q., Lai, F., Carter, K. C. and Nishikura,
K. (2000). A third member of the RNA-specific adenosine deaminase gene
family, ADAR3, contains both single- and double-stranded RNA binding
domains. RNA6, 755-767.
Choi, Y. D. and Dreyfuss, G. (1984). Monoclonal antibody characterization
of the C proteins of heterogeneous nuclear ribonucleoprotein complexes in
vertebrate cells. J. Cell Biol.99, 1997-2004.
Dabiri, G. A., Lai, F., Drakas, R. A. and Nishikura, K. (1996). Editing of
the GLuR-B ion channel RNA in vitro by recombinant double- stranded
RNA adenosine deaminase. EMBO J.15, 34-45.
Eckmann, C. R., Neunteufl, A., Pfaffstetter, L. and Jantsch, M. F. (2001).
1818
The human but not the XenopusRNA-editing enzyme ADAR1 has an
atypical nuclear localization signal and displays the characteristics of a
shuttling protein. Mol. Biol. Cell12, 1911-1924.
Gama-Carvalho, M., Krauss, R. D., Chiang, L., Valcarcel, J., Green, M.
R. and Carmo-Fonseca, M.(1997). Targeting of U2AF65 to sites of active
splicing in the nucleus. J. Cell Biol.137, 975-987.
George, C. X. and Samuel, C. E. (1999a). Characterization of the 5′-flanking
region of the human RNA-specific adenosine deaminase ADAR1gene and
identification of an interferon-inducible ADAR1promoter. Gene229, 203-
213.
George, C. X. and Samuel, C. E. (1999b). Human RNA-specific adenosine
deaminase ADAR1 transcripts possess alternative exon 1 structures that
initiate from different promoters, one constitutively active and the other
interferon inducible. Proc. Natl. Acad. Sci. USA96, 4621-4626.
Gerber, A. P. and Keller, W. (1999). An adenosine deaminase that generates
inosine at the wobble position of tRNAs. Science286, 1146-1149.
Gerber, A. P. and Keller, W. (2001). RNA editing by base deamination: more
enzymes, more targets, new mysteries. Trends Biochem. Sci. 26, 376-384.
Gerber, A., O’Connell, M. A. and Keller, W. (1997). Two forms of human
double-stranded RNA-specific editase 1 (hRED1) generated by the insertion
of an Alu cassette. RNA3, 453-463.
Gerber, A., Grosjean, H., Melcher, T. and Keller, W. (1998). Tad1p, a yeast
tRNA-specific adenosine deaminase, is related to the mammalian pre-
mRNA editing enzymes ADAR1 and ADAR2. EMBO J.17, 4780-4789.
Gott, J. M. and Emeson, R. B. (2000). Functions and mechanisms of RNA
editing. Annu. Rev. Genet. 34, 499-531.
Higuchi, M., Single, F. N., Kohler, M., Sommer, B., Sprengel, R. and
Seeburg, P. H. (1993). RNA editing of AMPA receptor subunit GluR-B: a
base-paired intron-exon structure determines position and efficiency. Cell
75, 1361-1370.
Higuchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N.,
Feldmeyer, D., Sprengel, R. and Seeburg, P. H. (2000). Point mutation in
an AMPA receptor gene rescues lethality in mice deficient in the RNA-
editing enzyme ADAR2. Nature406, 78-81.
Hough, R. F. and Bass, B. L. (2001). Adenosines deaminases that act on RNA.
In RNA Editing: Frontiers in Molecular Biology(ed. B. L. Bass), pp. 77-
108. Oxford University Press.
Hurst, S. R., Hough, R. F., Aruscavage, P. J. and Bass, B. L. (1995).
Deamination of mammalian glutamate receptor RNA by XenopusdsRNA
adenosine deaminase: similarities to in vivo RNA editing. RNA 1, 1051-
1060.
Kawakubo, K. and Samuel, C. E. (2000). Human RNA-specific adenosine
deaminase (ADAR1) gene specifies transcripts that initiate from a
constitutively active alternative promoter. Gene258, 165-172.
Keegan, L. P., Gerber, A. P., Brindle, J., Leemans, R., Gallo, A., Keller, W.
and O’Connell, M. A. (2000). The properties of a tRNA-specific adenosine
deaminase from Drosophila melanogastersupport an evolutionary link
between pre-mRNA editing and tRNA modification. Mol. Cell. Biol. 20,
825-833.
Keegan, L. P., Gallo, A. and O’Connell, M. A. (2001). The many roles of
an RNA editor. Nat. Rev. Genet.2, 869-878.
Keller, W., Wolf, J. and Gerber, A. (1999). Editing of messenger RNA
precursors and of tRNAs by adenosine to inosine conversion. FEBS Lett.
452, 71-76.
Kumar, M. and Carmichael, G. G. (1997). Nuclear antisense RNA induces
extensive adenosine modifications and nuclear retention of target transcripts.
Proc. Natl. Acad. Sci. USA94, 3542-3547.
Lafarga, M., Berciano, M. T., Garcia-Segura, L. M., Andres, M. A. and
Carmo-Fonseca, M. (1998). Acute osmotic/stress stimuli induce a transient
decrease of transcriptional activity in the neurosecretory neurons of
supraoptic nuclei. J. Neurocytol. 27, 205-217.
Lichter, P., Boyle, A. L., Cremer, T. and Ward, D. C. (1991). Analysis of
genes and chromosomes by nonisotopic in situ hybridization. Ge et. Anal.
Tech. Appl. 8, 24-35.
Lyon, C. E. and Lamond, A. I. (2000). The nucleolus. Curr. Biol. 10, R323.
Maas, S., Gerber, A. P. and Rich, A. (1999). Identification and
characterization of a human tRNA-specific adenosine deaminase related to
the ADAR family of pre-mRNA editing enzymes. Proc. Natl. Acad. Sci.
USA96, 8895-8900.
Melcher, T., Maas, S., Herb, A., Sprengel, R., Seeburg, P. H. and Higuchi,
M. (1996). A mammalian RNA editing enzyme. Nature379, 460-464.
Michael, W. M., Choi, M. and Dreyfuss, G. (1995). A nuclear export signal
in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein
export pathway. Cell 83, 415-422.
O’Connell, M. A., Krause, S., Higuchi, M., Hsuan, J. J., Totty, N. F., Jenny,
A. and Keller, W. (1995). Cloning of cDNAs encoding mammalian double-
stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 15, 1389-
1397.
O’Connell, M. A., Gerber, A. and Keller, W. (1997). Purification of human
double-stranded RNA-specific editase 1 (hRED1) involved in editing of
brain glutamate receptor B pre-mRNA. J. Biol. Chem. 272, 473-478.
O’Connell, M. A., Gerber, A. and Keegan, L. P. (1998). Purification of native
and recombinant double-stranded RNA-specific adenosine deaminases.
Methods15, 51-62.
Palladino, M. J., Keegan, L. P., O’Connell, M. A. and Reenan, R. A. (2000).
dADAR, a Drosophiladouble-stranded RNA-specific adenosine deaminase
is highly developmentally regulated and is itself a target for RNA editing.
RNA6, 1004-1018.
Patterson, J. B. and Samuel, C. E. (1995). Expression and regulation by
interferon of a double-stranded-RNA-specific adenosine deaminase from
human cells: evidence for two forms of the deaminase. Mol Cell. Biol. 15,
5376-5388.
Patton, D. E., Silva, T. and Bezanilla, F. (1997). RNA editing generates a
diverse array of transcripts encoding squid Kv2 K+ channels with altered
functional properties. Neuron19, 711-722.
Pederson, T. and Politz, J. C. (2000). The nucleolus and the four
ribonucleoproteins of translation. J. Cell Biol.148, 1091-1095.
Phair, R. D. and Misteli, T. (2000). High mobility of proteins in the
mammalian cell nucleus. Nature404, 604-609.
Pinol-Roma, S. and Dreyfuss, G. (1992). Shuttling of pre-mRNA binding
proteins between nucleus and cytoplasm. Nature355, 730-732.
Poulsen, H., Nilsson, J., Damgaard, C. K., Egebjerg, J. and Kjems, J.
(2001). CRM1 mediates the export of ADAR1 through a nuclear
export signal within the Z-DNA binding domain. Mol. Cell. Biol. 21, 7862-
7871.
Reimer, G., Pollard, K. M., Penning, C. A., Ochs, R. L., Lischwe, M. A.,
Busch, H. and Tan, E. M.(1987). Monoclonal autoantibody from a (New
Zealand black × New Zealand white)F1 mouse and some human
scleroderma sera target an Mr 34,000 nucleolar protein of the U3 RNP
particle. Arthritis Rheum.30, 793-800.
Scadden, A. D. and Smith, C. W. (2001). Specific cleavage of hyper-edited
dsRNAs. EMBO J.20, 4243-4252.
Singh, M. and Emeson, R. B. (2000). Adenosine-to-inosine RNA editing:
substrates and consequences. In RNA Editing: Frontiers in Molecular
Biology (ed. B. L. Bass), pp. 109-138. Oxford University Press.
Smith, H. C., Gott, J. M. and Hanson, M. R. (1997). A guide to RNA editing.
RNA3, 1105-1123.
Sommer, B., Kohler, M., Sprengel, R. and Seeburg, P. H. (1991). RNA
editing in brain controls a determinant of ion flow in glutamate-gated
channels. Cell 67, 11-19.
Taylor, J. M. (1990). Hepatitis delta virus: cisand transfunctions required for
replication. Cell 61, 371-373.
Wang, Q., Khillan, J., Gadue, P. and Nishikura, K. (2000). Requirement of
the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis.
Science290, 1765-1768.
Zhang, Z. and Carmichael, G. G. (2001). The fate of dsRNA in the nucleus:
a p54nrb-containing complex mediates the nuclear retention of
promiscuously A-to-I edited RNAs. Cell 106, 465-475.
Journal of Cell Science 116 (9)
